Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:53 PM
Ignite Modification Date:
2025-12-24 @ 5:53 PM
NCT ID:
NCT02933268
Eligibility Criteria:
Inclusion Criteria:
* Have given written informed consent to participate
* Aged 16 years or older
* Have a diagnosis of ADPKD (fulfilling radiological diagnostic criteria ± genetic evidence)
* eGFR ≥ 20ml/min/1.73m2
* Able to self-monitor urine SG
Exclusion Criteria:
* Inability to provide informed consent
* eGFR \< 20ml/min/1.73m2
* Fluid overload states e.g. heart failure, cirrhosis, or requirement for fluid restriction
* Confounding illness impacting on renal disease e.g. concomitant diabetes or glomerulonephritis
* Treatment with diuretics for fluid overload (those on diuretics for hypertension may participate in the trial after a run-in period of 2 weeks)
* Treatment with Tolvaptan in the last 4 weeks
* Pregnancy or breastfeeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT02933268
Study Brief:
Protocol Section:
NCT02933268